Fluent Announces First Quarter 2024 Financial Results Revenue of $66.0 million for Q1 2024Net loss of $6.3 million for Q1 2024Gross profit (exclusive of depreciation and amortization) of $18.6 million for Q1 2024Media margin of $22.1 million for Q1 2024Adjusted EBITDA of $0.7 million for Q1 2024Adjusted net loss of $4.2 million for Q1 2024 NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT), a leading data-driven performance marketing company, today reported financial results for the first quarter ended March 31, 2024. Don Patrick, Fluent’s Chief Executive Office...
Oncocyte Reports First Quarter 2024 Financial Results Conference Call on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: OCX), a precision diagnostics company, today reported financial results for the quarter ended March 31, 2024. Recent Highlights Announced global commercialization partnership with Bio-Rad Laboratories, Inc.On track to ship research use only (RUO) GraftAssure™ transplant monitoring test kits to initial customers in Asia, the U.S., and the EU in 2Q 2024. IVD kits are under development for FDA submission....
CHANDLER, Ariz.--(BUSINESS WIRE)-- Insight Enterprises, Inc. (NASDAQ: NSIT) (the “Company”) announced today that it has priced $500 million aggregate principal amount of 6.625% senior notes due 2032 (the “notes”). The Company expects to use the net proceeds of the offering to repay a portion of the outstanding borrowings under its senior secured revolving credit facility due 2027 and, to the extent of any remaining net proceeds, for general corporate purposes. The sale of the notes is expected to close on May 20, 2024, subject to customary closing conditions. The notes will be senior unsecur...
Moody's Ratings (Moody's) assigned a Ba2 Corporate Family Rating (CFR) and Ba2-PD Probability of Default Rating to Insight Enterprises, Inc. (Insight Enterprises). Moody's also assigned a Ba3 to the proposed senior unsecured notes and a SGL-2 Speculative Grade Liquidity (SGL) rating. Net proceeds fr...
CHANDLER, Ariz.--(BUSINESS WIRE)-- Insight Enterprises, Inc. (NASDAQ: NSIT) (the “Company”) announced today that it intends to offer, subject to market and other conditions, $500 million aggregate principal amount of Senior Notes due 2032 (the “notes”). The Company expects to use the net proceeds of the offering to repay a portion of the outstanding borrowings under its senior secured revolving credit facility due 2027 and, to the extent of any remaining net proceeds, for general corporate purposes. The notes will be senior unsecured obligations of the Company and will be guaranteed on a sen...
CHANDLER, Ariz.--(BUSINESS WIRE)-- Insight Enterprises, Inc. (Nasdaq: NSIT) (the “Company”) today announced that it is scheduled to participate in the following upcoming investor conference: J.P. Morgan 52nd Annual Global Technology, Media and Communications Conference Tuesday, May 21, 2024, 8:10 AM ET Participants: Glynis Bryan, CFO The Insight presentation will be broadcast live over the Internet at where you can also view other recent webcasts, downloadable slide presentations and other investor information. About Insight Insight Enterprises, Inc. is a global Fortune 500 Solutions ...
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, announced today a presentation at the European Hematology Association 2024 Congress, to be held June 13-16 in Madrid, Spain. “We’re excited to share the latest updated interim results from our Phase 1 trial evaluating our gamma-delta T cell therapy INB-100 after haploidentical stem cell transplantation for patients with leukemia at the upcoming EHA c...
Oncocyte to Announce First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, announced today that the company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, after U.S. market close. The company will host a conference call and webcast on Wednesday, May 15, 2024, at 4:30 p.m. Eastern Time to discuss its financial results and highlights. Interested parties may access the l...
IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation at ASGCT 2024 NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: INAB), a clinical-stage biopharmaceutical company advancing innovative gamma-delta T cell therapies, presented in an oral session details about its robust and reproducible proprietary clinical-scale gamma-delta T cell manufacturing platform across different donor populations, at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting. In an oral presentation titled: “Healthy Donor vs. Patient Manufac...
CHANDLER, Ariz.--(BUSINESS WIRE)-- Insight Enterprises, Inc. (Nasdaq: NSIT) (the “Company”) announced today that it intends to hold one or more meetings with potential investors with respect to a potential offering of senior notes (the “notes”) in a transaction exempt from the registration requirements under the Securities Act of 1933 (the "Offering"), the proceeds of which are expected to be used to repay a portion of the outstanding borrowings under its senior secured revolving credit facility due 2027 and, to the extent of any remaining net proceeds, for general corporate purposes. There ca...
IN8bio Reports First Quarter 2024 Financial Results and Recent Corporate Highlights - Presented new preclinical data demonstrating proof-of-concept for non-signaling Chimeric Antigen Receptor (nsCAR) platform to effectively target cancer cells while preserving healthy tissue - Demonstrated potential of nsCAR platform to treat previously “undruggable” solid and liquid tumor targets - Announced peer-reviewed publication in ‘Frontiers in Immunology’ on IN8bio’s DeltEx Drug Resistant Immunotherapy (DRI) approach to newly diagnosed glioblastoma multiforme (GBM) - Dosed first patient in auto...
Fluent, Inc. to Announce 2024 First Quarter Financial Results on May 15, 2024 NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT) announced today that it will report its financial results for the First Quarter 2024 after the close of the U.S. financial markets on May 15, 2024. Fluent will host a conference call at 4:30 pm ET on the same day to discuss the results. The conference call can be accessed by phone after registering online at or via audio at . The call will also be webcast simultaneously on the Fluent website on the . Please log in at least 15 minutes prior...
CHANDLER, Ariz.--(BUSINESS WIRE)-- Insight Enterprises, Inc. (NASDAQ: NSIT) (the “Company”) today reported financial results for the quarter ended March 31, 2024. Highlights include: Gross profit increased 13% year over year to a record $440.9 million with gross margin expanding 170 basis points to a first quarter record 18.5% Insight Core services gross profit grew 24% year over year Cloud gross profit grew 33% year over year First quarter record results: Earnings from operations increased 29% year over year to $100.0 million Adjusted earnings from operations increased 30% ...
CHANDLER, Ariz.--(BUSINESS WIRE)-- Insight Enterprises, Inc. (Nasdaq: NSIT) (the “Company”), announced today that Glynis Bryan plans to retire as Chief Financial Officer effective December 31, 2024. Ms. Bryan, 65, has been with the Company since December 17, 2007. Ms. Bryan will continue to serve as the Chief Financial Officer through the end of the year. She will then transition to an advisory role. The Company has engaged an executive search firm to identify and evaluate potential successors from internal and external candidates. Ms. Bryan will assist the Company in the search process. M...
CHANDLER, Ariz.--(BUSINESS WIRE)-- (NASDAQ: NSIT) announced it has , a fast-growing pure-play ServiceNow Elite Partner, adding a full complement of ServiceNow consulting, implementation and managed services to its automation solutions portfolio. Client demand for intelligent enterprise automation continues to grow rapidly, fueling a market that’s estimated at $220 billion by 2025. , the 2024 ServiceNow Americas Consulting and Implementation Partner of the Year, works with clients around the world to implement ServiceNow capabilities and pursue aggressive digital transformation goals. “Wor...
AgEagle Aerial Systems Announces its Drones Used by U.S. Army Corps of Engineers U.S. Army Corps of Engineers (USACE) completed its training for National Guardsman utilizing the AgEagle eBee TAC drone, along with other UAVseBee TAC is the first fixed-wing drone to be added to the DIU Blue UAS list and cleared to fly over humansFive-day, 32-hour training program prepares future crewmembers to operate Unmanned Aviation Systems (UAS) inside the National Airspace System WICHITA, Kan., May 01, 2024 (GLOBE NEWSWIRE) -- (NYSE: UAVS) a leading provider of best-in-class full stack unmanned aviat...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.